35 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 35 separate news trends connected to Glp-1S, spanning June 29, 2026 through October 27, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 305 article observations and 281 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Women on GLP‑1 weight‑loss drugs are voicing unexpected side‑effects and mixed satisfaction, sparking a clash of narratives across health media.
Women on GLP-1s share side effects and experiences not previously disclosed.
10 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
GLP-1 drugs may aid fertility for hopeful mothers, sparking new hope for couples.
People who rely on GLP-1s for weight loss face a daunting prospect: regaining weight after stopping treatment.
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
15M Americans take GLP-1 drugs, with some seeking cheaper alternatives due to high costs.
Scientists May Have Found a Way to Limit Weight Regain After Stopping GLP-1 Medicines
Some who take GLP-1s are suffering serious side effects, but it's unclear how often.
GLP-1s shift from 'patients' to 'customers' as weight loss trend surges
Novo Nordisk's shares dropped as Eli Lilly gains ground in GLP-1s
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
13 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Study finds link between GLP-1 drugs and nutritional deficiencies in children
18 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
700,000 seniors start GLP-1 treatments under Medicare, with 70% on Eli Lilly drugs
GLP-1s linked to nutritional deficiencies in nearly 1 in 6 children, raising questions about parental conversations.
GLP‑1 hype meets science as demand spikes, safety debates and efficacy doubts flood the media
New era of obesity medicines raises hopes for broader health benefits beyond weight loss.
A surge in GLP‑1 prescriptions turns personal weight‑loss choices into a public debate demanding explanations.
Recent scientific findings reveal specific brain mechanisms and proteins influencing fatty food cravings and weight loss treatments.
Men’s weight‑loss drugs face a double‑edge of stigma and rebound fears as GLP‑1 use spikes.
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
A national trial is exploring whether GLP-1s, known for weight loss, can also help with alcohol use disorder.
New research suggests that popular weight-loss drugs may work differently than previously understood.
The VA is launching a study to test GLP-1s for treating alcohol use disorder.
The rise of GLP-1 medications is rewriting the social norms of the modern office and challenging long-standing boundaries regarding body image.
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Medical professionals are warning that GLP-1 medications may lead to emotional flatness and a loss of "zest for life" alongside weight loss.
Peptides have emerged as a dominant wellness trend, sparking a commercial gold rush alongside growing warnings about unregulated black-market usage.
Researchers and doctors are exploring the broader implications of GLP-1 weight loss drugs as their use becomes more widespread.